Stay informed with the latest litigation news. Explore now

Ipsen Pharma competitive analysis

Latest publications and patents of Ipsen Pharma New

Explore the latest publications and patents granted to Ipsen Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 11, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ipsen Pharma

Jan 10, 2018Melanocortin Receptor LigandsNo Opposition Filed Within Time Limit
Jan 3, 2018Somatostatin-Dopamine Chimeric AnalogsNo Opposition Filed Within Time Limit
May 17, 2017A Stable Composition Comprising Pthrp And Uses ThereofRevoked
Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo BilobaRevoked

Explore patent oppositions filed by Ipsen Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
Lyophilized Preparation Of Botulinum ToxinMEDY TOXFeb 2, 2018

Explore Ipsen Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 17, 2017A Stable Composition Comprising Pthrp And Uses Thereof2
Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo Biloba1

Latest PTAB cases involving Ipsen Pharma New

Discover the latest PTAB cases involving Ipsen Pharma, highlighting their recent legal challenges and patent disputes.

Top competitors of Ipsen Pharma

Top competitors of Ipsen Pharma based on patent oppositions.